Skip to content

A Brave New World: Nutrition Complication of Novel Oncologic Therapies (T22)

Tuesday, March 5 • 9:45 AM – 11:15 AM ET

In Person_Virtual


  1. Identify the nutritional challenges associated with gastrointestinal graft versus host disease (GI GVHD).
  2. Describe the most common nutrition alterations encountered in patients receiving immunotherapy. 
  3. Describe the hyperthermic intraperitoneal chemotherapy (HIPEC) surgical procedure and nutrition implications.
  4. Develop treatment strategies for management of patients receiving novel cancer therapies.


Nutritional Complication Associated With Gastrointestinal Graft Versus Host Disease
Michelle Myers, MS, RDN, CSO, CDN, Outpatient Clinical Dietitian-Nutritionist, Memorial Sloan Kettering Cancer Center, New York, NY

Management of Immunotherapy-Related Gastrointestinal Toxicities
Lindsey Russell, MD, MSc, CNSC, FRCPC, Associate Staff and Gastroenterologist, Department of Gastroenterology, Hepatology, and Nutrition, Cleveland Clinic, Cleveland, OH

Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Surgeries: Overview and Nutritional Implications
Dana Cox, MPAS, PA-C, Supervisor, Advanced Practice Providers, The University of Texas MD Anderson Cancer Center, Houston, TX

Jose Pimiento, MD, FACS, Associate Professor, Gastrointestinal Surgical Oncology; Medical Director, Inpatient Surgical Service; Section Lead, Upper Gastrointestinal Tumors, Moffitt Cancer Center, Tampa, FL

CE Credit: 1.5 hours
Level: Intermediate
UAN: JA0002345-0000-24-070-L01-P

BCNSP Logo 2024  This session will be reviewed for BCNSP-approved recertification credit through Purdue University College of Pharmacy